Power systems are becoming more interconnected and complex. The distributed generation expands and spreads across the grids, reducing the distance between the load and the generation. In addition, several substations are aging after decades of operation and their equipment struggle to sustain the ever increasing fault levels. In this context, the fault current limiter (FCL) arrived as a solution to mitigate this problem. Considering the FCL devices, the resistive superconducting FCL (R-SFCL) is the most mature technology with potential to be produced in mass scale, due to its ability to quickly change its impedance during a fault current and its high current density capacity. In this paper, a novel R-SFCL topology is presented, which has an unique design that allows a compact size and the possibility of modulated assembly. These characteristics enable setups for various voltage and current levels. One advantage of this topology is the compromise between volume and high heat exchange that can reduce the recovery time under load. One bench prototype was modeled using the thermal–electrical analogy implemented in ATPDraw, tested in two different labs. Tests were performed at faults levels of 12 kA
peak
, 5 kA
rms
and 2.7 kA
rms
for 137 V. Measured and simulated results were compared, resulting in a relative error of less than 12%. Two contributions can be highlighted: the new design of the R-SFCL and the inclusion in the convection heat exchange model curves for the heating (during the quench) and cooling (after fault), which allows to predict the recovery under load.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.